APO Research
Talk to an analyst

APO RESEARCH · REPORT

Avian Influenza Vaccines

Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.

Selected research

Market Structure

Global Avian Influenza Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025196 pages

Choose your research edition.

Industry ResearchAvian Influenza Vaccines Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Avian Influenza Vaccines Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Avian Influenza Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Avian Influenza Vaccines Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Avian Influenza Vaccines Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.

Global Avian Influenza Vaccines key players include Merial, QYH Biotech, DHN, HVRI, etc. Global top four manufacturers hold a share over 80%.

China is the largest market, with a share about 45%, followed by Asia (Ex.China), and North America, both have a share about 40 percent.

Read the full market overview

In terms of product, Type H5 is the largest segment, with a share over 70%. And in terms of application, the largest application is Chicken, followed by Duck and Goose, etc.

This report provides an overview of the global Avian Influenza Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Avian Influenza Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Avian Influenza Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Avian Influenza Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Avian Influenza Vaccines Segment by Company

Merial

QYH Biotech

DHN

HVRI

CEVA

Elanco (Lohmann )

Yebio

Zoetis

FATRO

Kyoto Biken

CAVAC

Ringpu Biology

Vaksindo

ChengDu Tecbond

Sindh Poultry Vaccine Centre

Merck Animal Health

Medion

Avimex Animal Health

JOVAC

Bio-Labs

Avian Influenza Vaccines Segment by Type

H5+H7 Avian Influenza Vaccines

H9 Avian Influenza Vaccines

Avian Influenza Vaccines Segment by Application

Chicken Avian Influenza Vaccines

Duck & Goose Avian Influenza Vaccines

Other

Avian Influenza Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Avian Influenza Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Avian Influenza Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Avian Influenza Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Avian Influenza Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Avian Influenza Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Avian Influenza Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Avian Influenza Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Avian Influenza Vaccines Industry Trends Table 2. Avian Influenza Vaccines Industry Drivers Table 3. Avian Influenza Vaccines Industry Opportunities and Challenges Table 4. Avian Influenza Vaccines Industry Restraints Table 5. Global Avian Influenza Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Avian Influenza Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Avian Influenza Vaccines Sales by Manufacturers (M Doses) & (2021-2026) Table 8. Global Avian Influenza Vaccines Sales Market Share by Manufacturers Table 9. Global Avian Influenza Vaccines Average Sales Price (USD/K Doses) of Manufacturers (2021-2026) Table 10. Global Avian Influenza Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Avian Influenza Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Avian Influenza Vaccines Manufacturers, Product Type & Application Table 13. Global Avian Influenza Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Avian Influenza Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of H5+H7 Avian Influenza Vaccines Table 17. Major Manufacturers of H9 Avian Influenza Vaccines Table 18. Global Avian Influenza Vaccines Sales by Type 2021 VS 2025 VS 2032 (M Doses) Table 19. Global Avian Influenza Vaccines Sales by Type (2021-2026) & (M Doses) Table 20. Global Avian Influenza Vaccines Sales by Type (2027-2032) & (M Doses) Table 21. Global Avian Influenza Vaccines Sales Market Share by Type (2021-2026) Table 22. Global Avian Influenza Vaccines Sales Market Share by Type (2027-2032) Table 23. Global Avian Influenza Vaccines Revenue by Type 2021 VS 2025 VS 2032 (M Doses) Table 24. Global Avian Influenza Vaccines Revenue by Type (2021-2026) & (M Doses) Table 25. Global Avian Influenza Vaccines Revenue by Type (2027-2032) & (M Doses) Table 26. Global Avian Influenza Vaccines Revenue Market Share by Type (2021-2026) Table 27. Global Avian Influenza Vaccines Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Chicken Avian Influenza Vaccines Table 29. Major Manufacturers of Duck & Goose Avian Influenza Vaccines Table 30. Major Manufacturers of Other Table 31. Global Avian Influenza Vaccines Sales by Application 2021 VS 2025 VS 2032 (M Doses) Table 32. Global Avian Influenza Vaccines Sales by Application (2021-2026) & (M Doses) Table 33. Global Avian Influenza Vaccines Sales by Application (2027-2032) & (M Doses) Table 34. Global Avian Influenza Vaccines Sales Market Share by Application (2021-2026) Table 35. Global Avian Influenza Vaccines Sales Market Share by Application (2027-2032) Table 36. Global Avian Influenza Vaccines Revenue by Application 2021 VS 2025 VS 2032 (M Doses) Table 37. Global Avian Influenza Vaccines Revenue by Application (2021-2026) & (M Doses) Table 38. Global Avian Influenza Vaccines Revenue by Application (2027-2032) & (M Doses) Table 39. Global Avian Influenza Vaccines Revenue Market Share by Application (2021-2026) Table 40. Global Avian Influenza Vaccines Revenue Market Share by Application (2027-2032) Table 41. Global Avian Influenza Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Table 42. Global Avian Influenza Vaccines Sales by Region (2021-2026) & (M Doses) Table 43. Global Avian Influenza Vaccines Sales Market Share by Region (2021-2026) Table 44. Global Avian Influenza Vaccines Sales Forecasted by Region (2027-2032) & (M Doses) Table 45. Global Avian Influenza Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Avian Influenza Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 47. North America Avian Influenza Vaccines Sales by Country (2021-2026) & (M Doses) Table 48. North America Avian Influenza Vaccines Sales by Country (2027-2032) & (M Doses) Table 49. Europe Avian Influenza Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 50. Europe Avian Influenza Vaccines Sales by Country (2021-2026) & (M Doses) Table 51. Europe Avian Influenza Vaccines Sales by Country (2027-2032) & (M Doses) Table 52. Asia Pacific Avian Influenza Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 53. Asia Pacific Avian Influenza Vaccines Sales by Country (2021-2026) & (M Doses) Table 54. Asia Pacific Avian Influenza Vaccines Sales by Country (2027-2032) & (M Doses) Table 55. South America, Middle East and Africa Avian Influenza Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 56. South America, Middle East and Africa Avian Influenza Vaccines Sales by Country (2021-2026) & (M Doses) Table 57. South America, Middle East and Africa Avian Influenza Vaccines Sales by Country (2027-2032) & (M Doses) Table 58. Global Avian Influenza Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Avian Influenza Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Avian Influenza Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Avian Influenza Vaccines Revenue Market Share by Region (2021-2026) Table 62. Global Avian Influenza Vaccines Revenue Market Share by Region (2027-2032) Table 63. Merial Company Information Table 64. Merial Business Overview Table 65. Merial Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Merial Avian Influenza Vaccines Product Portfolio Table 67. Merial Recent Development Table 68. QYH Biotech Company Information Table 69. QYH Biotech Business Overview Table 70. QYH Biotech Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. QYH Biotech Avian Influenza Vaccines Product Portfolio Table 72. QYH Biotech Recent Development Table 73. DHN Company Information Table 74. DHN Business Overview Table 75. DHN Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. DHN Avian Influenza Vaccines Product Portfolio Table 77. DHN Recent Development Table 78. HVRI Company Information Table 79. HVRI Business Overview Table 80. HVRI Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. HVRI Avian Influenza Vaccines Product Portfolio Table 82. HVRI Recent Development Table 83. CEVA Company Information Table 84. CEVA Business Overview Table 85. CEVA Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. CEVA Avian Influenza Vaccines Product Portfolio Table 87. CEVA Recent Development Table 88. Elanco (Lohmann ) Company Information Table 89. Elanco (Lohmann ) Business Overview Table 90. Elanco (Lohmann ) Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Elanco (Lohmann ) Avian Influenza Vaccines Product Portfolio Table 92. Elanco (Lohmann ) Recent Development Table 93. Yebio Company Information Table 94. Yebio Business Overview Table 95. Yebio Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Yebio Avian Influenza Vaccines Product Portfolio Table 97. Yebio Recent Development Table 98. Zoetis Company Information Table 99. Zoetis Business Overview Table 100. Zoetis Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Zoetis Avian Influenza Vaccines Product Portfolio Table 102. Zoetis Recent Development Table 103. FATRO Company Information Table 104. FATRO Business Overview Table 105. FATRO Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. FATRO Avian Influenza Vaccines Product Portfolio Table 107. FATRO Recent Development Table 108. Kyoto Biken Company Information Table 109. Kyoto Biken Business Overview Table 110. Kyoto Biken Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Kyoto Biken Avian Influenza Vaccines Product Portfolio Table 112. Kyoto Biken Recent Development Table 113. CAVAC Company Information Table 114. CAVAC Business Overview Table 115. CAVAC Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. CAVAC Avian Influenza Vaccines Product Portfolio Table 117. CAVAC Recent Development Table 118. Ringpu Biology Company Information Table 119. Ringpu Biology Business Overview Table 120. Ringpu Biology Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Ringpu Biology Avian Influenza Vaccines Product Portfolio Table 122. Ringpu Biology Recent Development Table 123. Vaksindo Company Information Table 124. Vaksindo Business Overview Table 125. Vaksindo Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Vaksindo Avian Influenza Vaccines Product Portfolio Table 127. Vaksindo Recent Development Table 128. ChengDu Tecbond Company Information Table 129. ChengDu Tecbond Business Overview Table 130. ChengDu Tecbond Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. ChengDu Tecbond Avian Influenza Vaccines Product Portfolio Table 132. ChengDu Tecbond Recent Development Table 133. Sindh Poultry Vaccine Centre Company Information Table 134. Sindh Poultry Vaccine Centre Business Overview Table 135. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product Portfolio Table 137. Sindh Poultry Vaccine Centre Recent Development Table 138. Merck Animal Health Company Information Table 139. Merck Animal Health Business Overview Table 140. Merck Animal Health Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Merck Animal Health Avian Influenza Vaccines Product Portfolio Table 142. Merck Animal Health Recent Development Table 143. Medion Company Information Table 144. Medion Business Overview Table 145. Medion Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Medion Avian Influenza Vaccines Product Portfolio Table 147. Medion Recent Development Table 148. Avimex Animal Health Company Information Table 149. Avimex Animal Health Business Overview Table 150. Avimex Animal Health Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Avimex Animal Health Avian Influenza Vaccines Product Portfolio Table 152. Avimex Animal Health Recent Development Table 153. JOVAC Company Information Table 154. JOVAC Business Overview Table 155. JOVAC Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. JOVAC Avian Influenza Vaccines Product Portfolio Table 157. JOVAC Recent Development Table 158. Bio-Labs Company Information Table 159. Bio-Labs Business Overview Table 160. Bio-Labs Avian Influenza Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. Bio-Labs Avian Influenza Vaccines Product Portfolio Table 162. Bio-Labs Recent Development Table 163. Key Raw Materials Table 164. Raw Materials Key Suppliers Table 165. Avian Influenza Vaccines Distributors List Table 166. Avian Influenza Vaccines Customers List Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Avian Influenza Vaccines Product Image Figure 2. Global Avian Influenza Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Avian Influenza Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Avian Influenza Vaccines Sales (2021-2032) & (M Doses) Figure 5. Global Avian Influenza Vaccines Average Price (USD/K Doses) & (2021-2032) Figure 6. Global Top 5 and 10 Avian Influenza Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. H5+H7 Avian Influenza Vaccines Image Figure 9. H9 Avian Influenza Vaccines Image Figure 10. Global Avian Influenza Vaccines Sales by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 11. Global Avian Influenza Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Avian Influenza Vaccines Sales Market Share by Type (2021-2032) Figure 13. Global Avian Influenza Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 14. Global Avian Influenza Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Avian Influenza Vaccines Revenue Market Share by Type (2021-2032) Figure 16. Chicken Avian Influenza Vaccines Image Figure 17. Duck & Goose Avian Influenza Vaccines Image Figure 18. Other Image Figure 19. Global Avian Influenza Vaccines Sales by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 20. Global Avian Influenza Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Avian Influenza Vaccines Sales Market Share by Application (2021-2032) Figure 22. Global Avian Influenza Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 23. Global Avian Influenza Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Avian Influenza Vaccines Revenue Market Share by Application (2021-2032) Figure 25. North America Avian Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 26. North America Avian Influenza Vaccines Sales Market Share by Country (2021-2032) Figure 27. U.S. Avian Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 28. Canada Avian Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 29. Mexico Avian Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 30. Europe Avian Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 31. Europe Avian Influenza Vaccines Sales Market Share by Country (2021-2032) Figure 32. Germany Avian Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 33. France Avian Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 34. U.K. Avian Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 35. Italy Avian Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 36. Netherlands Avian Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 37. Asia Pacific Avian Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 38. Asia Pacific Avian Influenza Vaccines Sales Market Share by Country (2021-2032) Figure 39. China Avian Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 40. Japan Avian Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 41. South Korea Avian Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 42. Southeast Asia Avian Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 43. India Avian Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 44. Australia Avian Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 45. South America, Middle East and Africa Avian Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 46. South America, Middle East and Africa Avian Influenza Vaccines Sales Market Share by Country (2021-2032) Figure 47. Brazil Avian Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 48. South Africa Avian Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 49. Saudi Arabia Avian Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 50. Turkey Avian Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 51. Argentina Avian Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 52. UAE Avian Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 53. Egypt Avian Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 54. Chile Avian Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 55. Global Avian Influenza Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Avian Influenza Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Figure 58. North America Avian Influenza Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Figure 60. Europe Avian Influenza Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Avian Influenza Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Avian Influenza Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Avian Influenza Vaccines Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Avian Influenza Vaccines Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • H5+H7 Avian Influenza Vaccines
  • H9 Avian Influenza Vaccines
Applications
  • Chicken Avian Influenza Vaccines
  • Duck & Goose Avian Influenza Vaccines
  • Other
Companies covered
  • Merial
  • QYH Biotech
  • DHN
  • HVRI
  • CEVA
  • Elanco (Lohmann )
  • Yebio
  • Zoetis
  • FATRO
  • Kyoto Biken
  • CAVAC
  • Ringpu Biology
  • Vaksindo
  • ChengDu Tecbond
  • Sindh Poultry Vaccine Centre
  • Merck Animal Health
  • Medion
  • Avimex Animal Health
  • JOVAC
  • Bio-Labs

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Avian Influenza Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Avian Influenza Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Avian Influenza Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Avian Influenza Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Avian Influenza Vaccines Market Dynamics
  1. 2.1 Avian Influenza Vaccines Industry Trends
  2. 2.2 Avian Influenza Vaccines Industry Drivers
  3. 2.3 Avian Influenza Vaccines Industry Opportunities and Challenges
  4. 2.4 Avian Influenza Vaccines Industry Restraints
3 Avian Influenza Vaccines Market by Manufacturers
  1. 3.1 Global Avian Influenza Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Avian Influenza Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Avian Influenza Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Avian Influenza Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Avian Influenza Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Avian Influenza Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Avian Influenza Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Avian Influenza Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Avian Influenza Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Avian Influenza Vaccines Tier 1, Tier 2, and Tier 3
4 Avian Influenza Vaccines Market by Type
  1. 4.1 Avian Influenza Vaccines Type Introduction
  2. 4.1.1 H5+H7 Avian Influenza Vaccines
  3. 4.1.2 H9 Avian Influenza Vaccines
  4. 4.2 Global Avian Influenza Vaccines Sales by Type
  5. 4.2.1 Global Avian Influenza Vaccines Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Avian Influenza Vaccines Sales by Type (2021-2032)
  7. 4.2.3 Global Avian Influenza Vaccines Sales Market Share by Type (2021-2032)
  8. 4.3 Global Avian Influenza Vaccines Revenue by Type
  9. 4.3.1 Global Avian Influenza Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Avian Influenza Vaccines Revenue by Type (2021-2032)
  11. 4.3.3 Global Avian Influenza Vaccines Revenue Market Share by Type (2021-2032)
5 Avian Influenza Vaccines Market by Application
  1. 5.1 Avian Influenza Vaccines Application Introduction
  2. 5.1.1 Chicken Avian Influenza Vaccines
  3. 5.1.2 Duck & Goose Avian Influenza Vaccines
  4. 5.1.3 Other
  5. 5.2 Global Avian Influenza Vaccines Sales by Application
  6. 5.2.1 Global Avian Influenza Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Avian Influenza Vaccines Sales by Application (2021-2032)
  8. 5.2.3 Global Avian Influenza Vaccines Sales Market Share by Application (2021-2032)
  9. 5.3 Global Avian Influenza Vaccines Revenue by Application
  10. 5.3.1 Global Avian Influenza Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Avian Influenza Vaccines Revenue by Application (2021-2032)
  12. 5.3.3 Global Avian Influenza Vaccines Revenue Market Share by Application (2021-2032)
6 Global Avian Influenza Vaccines Sales by Region
  1. 6.1 Global Avian Influenza Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Avian Influenza Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Avian Influenza Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Avian Influenza Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Avian Influenza Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Avian Influenza Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Avian Influenza Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Avian Influenza Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Avian Influenza Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Avian Influenza Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Avian Influenza Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Avian Influenza Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Avian Influenza Vaccines Revenue by Region
  1. 7.1 Global Avian Influenza Vaccines Revenue by Region
  2. 7.1.1 Global Avian Influenza Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Avian Influenza Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Avian Influenza Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Avian Influenza Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Avian Influenza Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Avian Influenza Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Avian Influenza Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Avian Influenza Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Avian Influenza Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Avian Influenza Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Avian Influenza Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Avian Influenza Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Merial
  2. 8.1.1 Merial Company Information
  3. 8.1.2 Merial Business Overview
  4. 8.1.3 Merial Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merial Avian Influenza Vaccines Product Portfolio
  6. 8.1.5 Merial Recent Developments
  7. 8.2 QYH Biotech
  8. 8.2.1 QYH Biotech Company Information
  9. 8.2.2 QYH Biotech Business Overview
  10. 8.2.3 QYH Biotech Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 QYH Biotech Avian Influenza Vaccines Product Portfolio
  12. 8.2.5 QYH Biotech Recent Developments
  13. 8.3 DHN
  14. 8.3.1 DHN Company Information
  15. 8.3.2 DHN Business Overview
  16. 8.3.3 DHN Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 DHN Avian Influenza Vaccines Product Portfolio
  18. 8.3.5 DHN Recent Developments
  19. 8.4 HVRI
  20. 8.4.1 HVRI Company Information
  21. 8.4.2 HVRI Business Overview
  22. 8.4.3 HVRI Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 HVRI Avian Influenza Vaccines Product Portfolio
  24. 8.4.5 HVRI Recent Developments
  25. 8.5 CEVA
  26. 8.5.1 CEVA Company Information
  27. 8.5.2 CEVA Business Overview
  28. 8.5.3 CEVA Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CEVA Avian Influenza Vaccines Product Portfolio
  30. 8.5.5 CEVA Recent Developments
  31. 8.6 Elanco (Lohmann )
  32. 8.6.1 Elanco (Lohmann ) Company Information
  33. 8.6.2 Elanco (Lohmann ) Business Overview
  34. 8.6.3 Elanco (Lohmann ) Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Elanco (Lohmann ) Avian Influenza Vaccines Product Portfolio
  36. 8.6.5 Elanco (Lohmann ) Recent Developments
  37. 8.7 Yebio
  38. 8.7.1 Yebio Company Information
  39. 8.7.2 Yebio Business Overview
  40. 8.7.3 Yebio Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Yebio Avian Influenza Vaccines Product Portfolio
  42. 8.7.5 Yebio Recent Developments
  43. 8.8 Zoetis
  44. 8.8.1 Zoetis Company Information
  45. 8.8.2 Zoetis Business Overview
  46. 8.8.3 Zoetis Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Zoetis Avian Influenza Vaccines Product Portfolio
  48. 8.8.5 Zoetis Recent Developments
  49. 8.9 FATRO
  50. 8.9.1 FATRO Company Information
  51. 8.9.2 FATRO Business Overview
  52. 8.9.3 FATRO Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 FATRO Avian Influenza Vaccines Product Portfolio
  54. 8.9.5 FATRO Recent Developments
  55. 8.10 Kyoto Biken
  56. 8.10.1 Kyoto Biken Company Information
  57. 8.10.2 Kyoto Biken Business Overview
  58. 8.10.3 Kyoto Biken Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Kyoto Biken Avian Influenza Vaccines Product Portfolio
  60. 8.10.5 Kyoto Biken Recent Developments
  61. 8.11 CAVAC
  62. 8.11.1 CAVAC Company Information
  63. 8.11.2 CAVAC Business Overview
  64. 8.11.3 CAVAC Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 CAVAC Avian Influenza Vaccines Product Portfolio
  66. 8.11.5 CAVAC Recent Developments
  67. 8.12 Ringpu Biology
  68. 8.12.1 Ringpu Biology Company Information
  69. 8.12.2 Ringpu Biology Business Overview
  70. 8.12.3 Ringpu Biology Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Ringpu Biology Avian Influenza Vaccines Product Portfolio
  72. 8.12.5 Ringpu Biology Recent Developments
  73. 8.13 Vaksindo
  74. 8.13.1 Vaksindo Company Information
  75. 8.13.2 Vaksindo Business Overview
  76. 8.13.3 Vaksindo Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Vaksindo Avian Influenza Vaccines Product Portfolio
  78. 8.13.5 Vaksindo Recent Developments
  79. 8.14 ChengDu Tecbond
  80. 8.14.1 ChengDu Tecbond Company Information
  81. 8.14.2 ChengDu Tecbond Business Overview
  82. 8.14.3 ChengDu Tecbond Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 ChengDu Tecbond Avian Influenza Vaccines Product Portfolio
  84. 8.14.5 ChengDu Tecbond Recent Developments
  85. 8.15 Sindh Poultry Vaccine Centre
  86. 8.15.1 Sindh Poultry Vaccine Centre Company Information
  87. 8.15.2 Sindh Poultry Vaccine Centre Business Overview
  88. 8.15.3 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product Portfolio
  90. 8.15.5 Sindh Poultry Vaccine Centre Recent Developments
  91. 8.16 Merck Animal Health
  92. 8.16.1 Merck Animal Health Company Information
  93. 8.16.2 Merck Animal Health Business Overview
  94. 8.16.3 Merck Animal Health Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Merck Animal Health Avian Influenza Vaccines Product Portfolio
  96. 8.16.5 Merck Animal Health Recent Developments
  97. 8.17 Medion
  98. 8.17.1 Medion Company Information
  99. 8.17.2 Medion Business Overview
  100. 8.17.3 Medion Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Medion Avian Influenza Vaccines Product Portfolio
  102. 8.17.5 Medion Recent Developments
  103. 8.18 Avimex Animal Health
  104. 8.18.1 Avimex Animal Health Company Information
  105. 8.18.2 Avimex Animal Health Business Overview
  106. 8.18.3 Avimex Animal Health Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Avimex Animal Health Avian Influenza Vaccines Product Portfolio
  108. 8.18.5 Avimex Animal Health Recent Developments
  109. 8.19 JOVAC
  110. 8.19.1 JOVAC Company Information
  111. 8.19.2 JOVAC Business Overview
  112. 8.19.3 JOVAC Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 JOVAC Avian Influenza Vaccines Product Portfolio
  114. 8.19.5 JOVAC Recent Developments
  115. 8.20 Bio-Labs
  116. 8.20.1 Bio-Labs Company Information
  117. 8.20.2 Bio-Labs Business Overview
  118. 8.20.3 Bio-Labs Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Bio-Labs Avian Influenza Vaccines Product Portfolio
  120. 8.20.5 Bio-Labs Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Avian Influenza Vaccines Value Chain Analysis
  2. 9.1.1 Avian Influenza Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Avian Influenza Vaccines Production Mode & Process
  6. 9.2 Avian Influenza Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Avian Influenza Vaccines Distributors
  9. 9.2.3 Avian Influenza Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst